肺ドラッグデリバリーシステム（PDDS）の世界市場（～2026年）

• 英文タイトル：Global Pulmonary Drug Delivery System (PDDS) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04415
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は肺ドラッグデリバリーシステム（PDDS）のグローバル市場について調査・分析したレポートです。種類別（エアロゾル、エアロゾル吸入剤）市場規模、用途別（喘息、慢性気管支炎、肺感染症、閉塞性肺気腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別肺ドラッグデリバリーシステム（PDDS）の競争状況、市場シェア
・世界の肺ドラッグデリバリーシステム（PDDS）市場：種類別市場規模 2015年-2020年（エアロゾル、エアロゾル吸入剤）
・世界の肺ドラッグデリバリーシステム（PDDS）市場：種類別市場規模予測 2021年-2026年（エアロゾル、エアロゾル吸入剤）
・世界の肺ドラッグデリバリーシステム（PDDS）市場：用途別市場規模 2015年-2020年（喘息、慢性気管支炎、肺感染症、閉塞性肺気腫、その他）
・世界の肺ドラッグデリバリーシステム（PDDS）市場：用途別市場規模予測 2021年-2026年（喘息、慢性気管支炎、肺感染症、閉塞性肺気腫、その他）
・北米の肺ドラッグデリバリーシステム（PDDS）市場分析：米国、カナダ
・ヨーロッパの肺ドラッグデリバリーシステム（PDDS）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肺ドラッグデリバリーシステム（PDDS）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肺ドラッグデリバリーシステム（PDDS）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肺ドラッグデリバリーシステム（PDDS）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Roche、3M、Innovative Devices、Eli Lilly、Inhale、Genteon
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Pulmonary Drug Delivery System (PDDS) Market
The global Pulmonary Drug Delivery System (PDDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Pulmonary Drug Delivery System (PDDS) Scope and Market Size
Pulmonary Drug Delivery System (PDDS) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Drug Delivery System (PDDS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Roche
3M
Innovative Devices
Eli Lilly
Inhale
Genteon
…

Market segment by Type, the product can be split into
Aerosol
Aerosolized Inhalants
Market segment by Application, split into
Asthma
Chronic Bronchitis
Lung Infection
Obstructive Emphysema
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pulmonary Drug Delivery System (PDDS) Revenue
1.4 Market by Type
1.4.1 Global Pulmonary Drug Delivery System (PDDS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Aerosol
1.4.3 Aerosolized Inhalants
1.5 Market by Application
1.5.1 Global Pulmonary Drug Delivery System (PDDS) Market Share by Application: 2020 VS 2026
1.5.2 Asthma
1.5.3 Chronic Bronchitis
1.5.4 Lung Infection
1.5.5 Obstructive Emphysema
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pulmonary Drug Delivery System (PDDS) Market Perspective (2015-2026)
2.2 Global Pulmonary Drug Delivery System (PDDS) Growth Trends by Regions
2.2.1 Pulmonary Drug Delivery System (PDDS) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pulmonary Drug Delivery System (PDDS) Historic Market Share by Regions (2015-2020)
2.2.3 Pulmonary Drug Delivery System (PDDS) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pulmonary Drug Delivery System (PDDS) Market Growth Strategy
2.3.6 Primary Interviews with Key Pulmonary Drug Delivery System (PDDS) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Drug Delivery System (PDDS) Players by Market Size
3.1.1 Global Top Pulmonary Drug Delivery System (PDDS) Players by Revenue (2015-2020)
3.1.2 Global Pulmonary Drug Delivery System (PDDS) Revenue Market Share by Players (2015-2020)
3.1.3 Global Pulmonary Drug Delivery System (PDDS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pulmonary Drug Delivery System (PDDS) Market Concentration Ratio
3.2.1 Global Pulmonary Drug Delivery System (PDDS) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery System (PDDS) Revenue in 2019
3.3 Pulmonary Drug Delivery System (PDDS) Key Players Head office and Area Served
3.4 Key Players Pulmonary Drug Delivery System (PDDS) Product Solution and Service
3.5 Date of Enter into Pulmonary Drug Delivery System (PDDS) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pulmonary Drug Delivery System (PDDS) Historic Market Size by Type (2015-2020)
4.2 Global Pulmonary Drug Delivery System (PDDS) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)
5.2 Global Pulmonary Drug Delivery System (PDDS) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
6.2 Pulmonary Drug Delivery System (PDDS) Key Players in North America (2019-2020)
6.3 North America Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
6.4 North America Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
7.2 Pulmonary Drug Delivery System (PDDS) Key Players in Europe (2019-2020)
7.3 Europe Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
7.4 Europe Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

8 China
8.1 China Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
8.2 Pulmonary Drug Delivery System (PDDS) Key Players in China (2019-2020)
8.3 China Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
8.4 China Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
9.2 Pulmonary Drug Delivery System (PDDS) Key Players in Japan (2019-2020)
9.3 Japan Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
9.4 Japan Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
10.2 Pulmonary Drug Delivery System (PDDS) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
10.4 Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

11 India
11.1 India Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
11.2 Pulmonary Drug Delivery System (PDDS) Key Players in India (2019-2020)
11.3 India Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
11.4 India Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pulmonary Drug Delivery System (PDDS) Market Size (2015-2020)
12.2 Pulmonary Drug Delivery System (PDDS) Key Players in Central & South America (2019-2020)
12.3 Central & South America Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020)
12.4 Central & South America Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Pulmonary Drug Delivery System (PDDS) Introduction
13.1.4 Pfizer Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Pulmonary Drug Delivery System (PDDS) Introduction
13.2.4 Roche Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020)
13.2.5 Roche Recent Development
13.3 3M
13.3.1 3M Company Details
13.3.2 3M Business Overview
13.3.3 3M Pulmonary Drug Delivery System (PDDS) Introduction
13.3.4 3M Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020)
13.3.5 3M Recent Development
13.4 Innovative Devices
13.4.1 Innovative Devices Company Details
13.4.2 Innovative Devices Business Overview
13.4.3 Innovative Devices Pulmonary Drug Delivery System (PDDS) Introduction
13.4.4 Innovative Devices Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020)
13.4.5 Innovative Devices Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Pulmonary Drug Delivery System (PDDS) Introduction
13.5.4 Eli Lilly Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020)
13.5.5 Eli Lilly Recent Development
13.6 Inhale
13.6.1 Inhale Company Details
13.6.2 Inhale Business Overview
13.6.3 Inhale Pulmonary Drug Delivery System (PDDS) Introduction
13.6.4 Inhale Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020)
13.6.5 Inhale Recent Development
13.7 Genteon
13.7.1 Genteon Company Details
13.7.2 Genteon Business Overview
13.7.3 Genteon Pulmonary Drug Delivery System (PDDS) Introduction
13.7.4 Genteon Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020)
13.7.5 Genteon Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Pulmonary Drug Delivery System (PDDS) Key Market Segments
Table 2. Key Players Covered: Ranking by Pulmonary Drug Delivery System (PDDS) Revenue
Table 3. Ranking of Global Top Pulmonary Drug Delivery System (PDDS) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pulmonary Drug Delivery System (PDDS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Aerosol
Table 6. Key Players of Aerosolized Inhalants
Table 7. Global Pulmonary Drug Delivery System (PDDS) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pulmonary Drug Delivery System (PDDS) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pulmonary Drug Delivery System (PDDS) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pulmonary Drug Delivery System (PDDS) Market Share by Regions (2015-2020)
Table 11. Global Pulmonary Drug Delivery System (PDDS) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pulmonary Drug Delivery System (PDDS) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pulmonary Drug Delivery System (PDDS) Market Growth Strategy
Table 17. Main Points Interviewed from Key Pulmonary Drug Delivery System (PDDS) Players
Table 18. Global Pulmonary Drug Delivery System (PDDS) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pulmonary Drug Delivery System (PDDS) Market Share by Players (2015-2020)
Table 20. Global Top Pulmonary Drug Delivery System (PDDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery System (PDDS) as of 2019)
Table 21. Global Pulmonary Drug Delivery System (PDDS) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pulmonary Drug Delivery System (PDDS) Product Solution and Service
Table 24. Date of Enter into Pulmonary Drug Delivery System (PDDS) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pulmonary Drug Delivery System (PDDS) Market Size Share by Type (2015-2020)
Table 28. Global Pulmonary Drug Delivery System (PDDS) Revenue Market Share by Type (2021-2026)
Table 29. Global Pulmonary Drug Delivery System (PDDS) Market Size Share by Application (2015-2020)
Table 30. Global Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pulmonary Drug Delivery System (PDDS) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 34. North America Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 36. North America Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 38. Europe Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 40. Europe Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 42. Europe Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 44. China Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 46. China Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 47. China Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 48. China Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 49. China Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 50. Japan Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 52. Japan Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 54. Japan Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 58. Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 60. Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 62. India Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 64. India Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 65. India Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 66. India Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 67. India Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pulmonary Drug Delivery System (PDDS) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pulmonary Drug Delivery System (PDDS) Market Share (2019-2020)
Table 70. Central & South America Pulmonary Drug Delivery System (PDDS) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pulmonary Drug Delivery System (PDDS) Market Share by Type (2015-2020)
Table 72. Central & South America Pulmonary Drug Delivery System (PDDS) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pulmonary Drug Delivery System (PDDS) Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. 3M Company Details
Table 85. 3M Business Overview
Table 86. 3M Product
Table 87. 3M Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 88. 3M Recent Development
Table 89. Innovative Devices Company Details
Table 90. Innovative Devices Business Overview
Table 91. Innovative Devices Product
Table 92. Innovative Devices Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 93. Innovative Devices Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Product
Table 97. Eli Lilly Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 98. Eli Lilly Recent Development
Table 99. Inhale Company Details
Table 100. Inhale Business Overview
Table 101. Inhale Product
Table 102. Inhale Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 103. Inhale Recent Development
Table 104. Genteon Company Details
Table 105. Genteon Business Overview
Table 106. Genteon Product
Table 107. Genteon Revenue in Pulmonary Drug Delivery System (PDDS) Business (2015-2020) (Million US$)
Table 108. Genteon Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Drug Delivery System (PDDS) Market Share by Type: 2020 VS 2026
Figure 2. Aerosol Features
Figure 3. Aerosolized Inhalants Features
Figure 4. Global Pulmonary Drug Delivery System (PDDS) Market Share by Application: 2020 VS 2026
Figure 5. Asthma Case Studies
Figure 6. Chronic Bronchitis Case Studies
Figure 7. Lung Infection Case Studies
Figure 8. Obstructive Emphysema Case Studies
Figure 9. Other Case Studies
Figure 10. Pulmonary Drug Delivery System (PDDS) Report Years Considered
Figure 11. Global Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pulmonary Drug Delivery System (PDDS) Market Share by Regions: 2020 VS 2026
Figure 13. Global Pulmonary Drug Delivery System (PDDS) Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pulmonary Drug Delivery System (PDDS) Market Share by Players in 2019
Figure 16. Global Top Pulmonary Drug Delivery System (PDDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery System (PDDS) as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pulmonary Drug Delivery System (PDDS) Revenue in 2019
Figure 18. North America Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pulmonary Drug Delivery System (PDDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

肺/呼吸器ドラッグデリバリーの世界市場（～2026年）

Global Pulmonary/ Respiratory Drug Delivery Market Size, Status and Forecast 2020-2026
MRC2-11QY04417 2020年11月20日 92Pages
当調査資料は肺/呼吸器ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤）市場規模、用途別（病院、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

埋め込み型ドラッグデリバリーシステム（DDS）の世界市場（～2026年）

Global Implantable Drug Delivery Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY12320 2020年11月25日 90Pages
当調査資料は埋め込み型ドラッグデリバリーシステム（DDS）のグローバル市場について調査・分析したレポートです。種類別（生分解性、非生分解性）市場規模、用途別（糖尿病性網膜症、心血管疾患、結腸直腸癌、骨粗鬆症、眼疾患、脳腫瘍、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、...

局所ドラッグデリバリーシステムの世界市場（～2026年）

Global Topical Drug Delivery System Market Size, Status and Forecast 2020-2026
MRC2-11QY04865 2020年11月20日 96Pages
当調査資料は局所ドラッグデリバリーシステムのグローバル市場について調査・分析したレポートです。種類別（皮膚ドラッグデリバリー、眼科ドラッグデリバリー、直腸ドラッグデリバリー、膣ドラッグデリバリー、経鼻ドラッグデリバリー）市場規模、用途別（病院・私立クリニック、在宅介護施設、その他）市場規模、地域別（...

鎮痛剤デリバリーの世界市場（～2026年）

Global Pain Drug Delivery Market Size, Status and Forecast 2020-2026
MRC2-11QY04144 2020年11月20日 96Pages
当調査資料は鎮痛剤デリバリーのグローバル市場について調査・分析したレポートです。種類別（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）市場規模、用途別（腫瘍、神経障害、肺疾患、ホルモン障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

ドラッグデリバリーシステム（DDS）の世界市場（～2026年）

Global Drug Delivery Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY11715 2020年11月25日 96Pages
当調査資料はドラッグデリバリーシステム（DDS）のグローバル市場について調査・分析したレポートです。種類別（子宮内インプラント、プロドラッグインプラント、ポリマードラッグデリバリー、標的化ドラッグデリバリー）市場規模、用途別（感染症、腫瘍、泌尿器科、糖尿病、中枢神経系）市場規模、地域別（北米、米国、...

マイクロニードルドラッグデリバリーシステム（DDS）の世界市場（～2026年）

Global Microneedle Drug Delivery Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY12684 2020年11月25日 94Pages
当調査資料はマイクロニードルドラッグデリバリーシステム（DDS）のグローバル市場について調査・分析したレポートです。種類別（中空マイクロニードル技術、固体マイクロニードル技術、溶解マイクロニードル技術）市場規模、用途別（ドラッグデリバリー、ワクチンデリバリー、その他）市場規模、地域別（北米、米国、カ...

高度ドラッグデリバリーシステムの世界市場（～2026年）

Global Advanced Drug Delivery Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY13587 2020年11月30日 92Pages
当調査資料は高度ドラッグデリバリーシステムのグローバル市場について調査・分析したレポートです。種類別（経口ドラッグデリバリー、肺ドラッグデリバリー、経皮ドラッグデリバリー、非経口ドラッグデリバリー）市場規模、用途別（病院、専門クリニック、臨床研究開発センター）市場規模、地域別（北米、米国、カナダ、ヨ...

徐放性経口用ドラッグデリバリー技術の世界市場（～2026年）

Global Oral Controlled Release Drug Delivery Technology Market Size, Status and Forecast 2020-2026
MRC2-11QY04079 2020年11月20日 93Pages
当調査資料は徐放性経口用ドラッグデリバリー技術のグローバル市場について調査・分析したレポートです。種類別（拡散制御放出システム、溶解制御放出システム、浸透圧制御放出システム、溶解および拡散制御放出システム、イオン交換樹脂制御放出、流体力学的ドラッグデリバリーシステム、その他）市場規模、用途別（医薬品...

ドラッグデリバリー技術の世界市場（～2026年）

Global Drug Delivery Technologies Market Size, Status and Forecast 2020-2026
MRC2-11QY11716 2020年11月25日 90Pages
当調査資料はドラッグデリバリー技術のグローバル市場について調査・分析したレポートです。種類別（経口ドラッグデリバリー、肺ドラッグデリバリー、注射薬デリバリー、眼ドラッグデリバリー、経鼻ドラッグデリバリー、局所ドラッグデリバリー、埋め込み型ドラッグデリバリー、経粘膜ドラッグデリバリー）市場規模、用途別...

注射可能型ドラッグデリバリーの世界市場（～2026年）

Global Injectable Drug Delivery Market Size, Status and Forecast 2020-2026
MRC2-11QY12383 2020年11月25日 92Pages
当調査資料は注射可能型ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（皮膚注射、循環器/筋骨格注射、臓器注射、中枢神経系注射）市場規模、用途別（病院・クリニック、在宅医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

肺/呼吸器ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 32810 million by 2026, from US$ 31560 million in 2020, at a CAGR of 3.7%% during 2021-2026. Global Pulmonary/ Respiratory Drug Delive…
局所ドラッグデリバリーシステムの世界市場（～2026年） Market Analysis and Insights: Global Topical Drug Delivery System Market The global Topical Drug Delivery System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Topical Drug Delivery System Scope and Market Size Topica…
鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
慢性閉塞性肺疾患（COPD）の世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
高度ドラッグデリバリーシステムの世界市場（～2026年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…